Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation

Laboratory Investigation

Volumn 78, Issue 8, 1998, Pages 987-1003

  Slevin, Mark ^a   Krupinski, Jerzy ^a   Kumar, Shant ^b   Gaffney, John ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; PROTEIN TYROSINE KINASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; BIOLOGICAL TRANSPORT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CATTLE; CELL DIVISION; CELL NUCLEUS; CELLS, CULTURED; CHICKENS; CYTOPLASM; DISACCHARIDES; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INDUCTION; FLAVONOIDS; HYALURONIC ACID; MALE; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGENS; MOLECULAR WEIGHT; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTORS, ANTIGEN; SIGNAL TRANSDUCTION;

EID: 0031849685     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel AR (1995). PD09859 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
2. Bertrand P, Girard N, Delpech P, Duval C, d'Anjou J, and Dauce P (1992). Hyaluronan and hyaluronectin in the extra-cellular matrix of human breast carcinoma. Int J Cancer 52:1-6.
3. Blenis J (1993). Signal transduction via the MAP kinases: Proceed at your own risk. Proc Natl Acad Sci USA 90:5889-5892.
4. Cacace AM, Ueffing M, Philipps A, Han EKH, Kolch W, and Weinstein CIB (1996). PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. Oncogene 13: 2517-2526.
5. Chen Q, Lin TH, Der CJ, and Juliano RL (1994). Integrin-mediated activation of mitogen-activated protein (MAP) or extracellular signal-regulated kinase (ERK) is independent of Ras. J Biol Chem 271:18122-18127.
6. Cohen P (1997). The search for physiological substrates of MAP and SAP kinases in mammalian cells. TICS 7:353-361.
7. Dabrowski A, VanderKuur JA, Carter SC, and Williams JA (1996). Cholecystokinin stimulates formation of shc-grb2 complex in rat pancreatic acinar cells through a protein kinase C-dependent mechanism. J Biol Chem 271:27125-27129.
8. Daum G, Eisenmann-Tappe I, Fries HW, Troppmair J, and Rapp U (1994). The ins and outs of Raf kinases. Trends Biochem Sci 19:474-480.
9. Daviet I, Herbert JM, and Maffrand JP (1990). Involvement of protein kinase C in the mitogenic and chemotaxis effects of basic fibroblast growth factor on bovine cerebral cortex capillary endothelial cells. FEBS Lett 259:315-317.
10. Deed R, Rooney P, Kumar P, Norton JD, and Kumar S (1997). Early response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells: Inhibition by non-angiogenic, high molecular weigh hyaluronan. Int J Cancer 71:251-256.
11. Ha oncogene are mediated by protein kinase Ca. Cancer Res 54:6413-6420.
12. Entwistle J, Hall CL, and Turley EA (1996). HA receptors, regulators of signalling to the cytoskeleton. J Cell Biochem 61:569-577.
13. Farese RV and Cooper DR (1991). Peptide hormone action: A practical approach. In: Siddle K and Hutton JC, editors: Lipid-related second messengers. Oxford: Oxford UP, 205-206.
14. Folkman J (1996). Fighting cancer by attacking its blood supply. Sci Am 231:116-119.
15. Hall CL, Lange LA, Prober DA, Zhang S, and Turley EA (1996). Pp60 (c-src) is required for cell locomotion regulated by the hyaluronan receptor RHAMM. Oncogene 13:2213-2224.
16. Hall CL, Wang C, Lange LL, and Turley E (1994). Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 126:575-588.
17. Harrington EO, Loffler J, Nelson PR, Kent KC, Simons M, and Ware JA (1997). Enhancement of migration by protein kinase Cα and inhibition of proliferation and cell cycle progression by protein kinase Cδ in capillary endothelial cells. J Biol Chem 272:7390-7397.
18. Hawker J and Granger H (1994). Tyrosine kinase inhibitors impair fibroblast growth factor signalling in coronary endothelial cells. Am J Physiol 266:H107-H120.
19. Hirata S, Akamarsu S, Matsubara T, Mizuno K, and Ishikawa H (1993). In vitro angiogenesis induced by oligosaccharides of hyaluronic acid. Arthritis Rheum 36(Suppl):247.
20. Irvine R (1996). Taking stock of Pi-PLC. Nature 380:581-583.
21. Kazanietz M, Areces LB, Bahador A, Mischak H, Goodnight J, Mushinski JF, and Blumberg PM (1993). Characterization of ligand and substrate specificity for the calcium-dependent protein kinase C isozymes. Mol Pharmacol 44:298-307.
22. Knudson W, Biswas C, Li XQ, Nemee RE, and Toole BP (1989). The role and regulation of tumour associated hyaluronan. In: Evered D and Whelan J, editors: The biology of hyaluronan. Chichester, UK: Wiley and Sons, 150-169.
23. 3H] phorbol 12:13-dibutyrate binding by various tumour promoters in mouse brain cytosol. Cancer Res 45:1958-1963.
24. Lees VC, Fan TPD, and West DC (1994). Angiogenesis in a delayed revascularisation model is accelerated by mitogenic oligosaccharides and hyaluronan. J Invest Dermatol 103: 576-579.
25. Lin N and Bazan H (1992). Protein kinase C subspecies in rabbit corneal epithelium: Increased activity of subspecies during wound healing. Curr Eye Res 11:899-907.
26. Lokeshwar VB, Iida N, and Bourginon LYW (1996). The cell adhesion molecule GP116 is a new CD44 variant (ex140) involved in hyaluronan and endothelial cell proliferation. J Biol Chem 271:23853-23864.
27. Mapelli E, Banfi P, Sala E, Sensi M, Supino F, Zunio F, and Gambetta R (1994). Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoforms. Int J Cancer 57:281-286.
28. Mechta F, Piette J, Hirai SL, and Yaniv M (1989). Stimulation of protein kinase C or protein kinase A mediated signal transduction pathways shows three modes of response among serum inducible genes. New Biol 1:297-304.
29. Montesano R, Kumar S, Orci L, and Pepper MS (1996). Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest 75:211-226.
30. Nishizuka Y (1986). Studies and perspectives on protein kinase C. Science 233:305-311.
31. Ohtsuka T, Kaziro Y, and Satoh T (1996). Analysis of the T-cell activation signalling pathway mediated by tyrosine kinases, protein kinase C, and ras protein which is modulated by intracellular cyclic AMP. Biochim Biophys Acta 1310:223-232.
32. Pang L, Sawada T, Decker S, and Saltiel A (1995). Inhibition of MAP kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588.
33. Pepper MS (1997). Manipulating angiogenesis, from basic science to the bedside. Arterioscler Thromb Vase Biol 7:605-619.
34. Ponting J, Kumar S, and Pye D (1993). Localization of hyaluronan and hyaluronectin in normal and tumour breast tissue. Int J Oncol 2:889-893.
35. Presta M, Tiberio L, Rusnati E, and Ragnotti G (1991). Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. Cell Regul 2:719-726.
36. Rebba A, Hurh J, Yamamato H, Kersey DS, and Bremer EG (1996). Ganglioside GM3 inhibition of EGF receptor-mediated signal transduction. Glycobiology 6:399-406.
37. Rooney P and Kumar S (1993). Inverse relationship between hyaluronan and collagens in development and angiogenesis. Differentiation 54:1-9.
38. Rooney P, Kumar P, Ponting S, and Kumar S (1997). The role of proteoglycans in tumour angiogenesis. In: Bicknell R, Lewis CE, Ferrera N, editors: Tumour angiogenesis. Oxford: Oxford University Press, 141-161.
39. Rooney P, Kumar S, Ponting J, and Wang M (1995). The role of hyaluronan in tumour neovascularization. Int J Cancer 60:632-636.
40. Sa G, Murugeson G, Jaye M, Ivashcenko Y, and Fox PL (1995). Activity of cytosolic phospholipase A2 by basic fibroblast growth factor via a P42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem 270:2360-2366.
41. Sattar A, Rooney P, Kumar S, Pye D, West DC, Scott I, and Ledger P (1994). Application of angiogenic oligosaccharides of hyaluronan increase blood-vessel numbers in skin. J Invest Dermatol 103:576-579.
42. Seger R (1996). The mitogen-activated protein kinase cascades. Sigma Immuno Notes, No 14.
43. 2M phase transition of cell cycle. J Biol Chem 271:15045-15053.
44. Toker A and Cantley C (1997). Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676.
45. Toole BP, Munaim SI, Welles S, and Knudson CB (1989). Hyaluronate-cell interactions and growth-factor regulation of hyaluronate synthesis during limb development. In: Evered D and Whelan J, editors: The biology of hyaluronan. Chichester, UK: Wiley and Sons, 138-149.
46. Troppmair J, Brunder JT, Munoz H, Lloyd PA, Kyriakis J, Banerjee P, Avruch J, and Rapp UR (1994). Mitogenactivated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J Biol Chem 269:7030-7035.
47. Turley EA and Tretaik M (1985). Glycosaminoglycans produced by murine melanoma variants in vivo and in vitro. Cancer Res 45:5098-6015.
48. Vainikka S, Joukou V, Wennistrom S, Bergman M, Pelicci P, and Alitalo K (1994). Signal transduction by fibroblast growth factor receptor-4 (FGFR-4): Comparison with FGFR-1. J Biol Chem 269:18320-18326.
49. Vanhaesbroek B, Leevers SJ, Panayoto G, and Waterfield MD (1997). Phosphoinositide 3-kinases: A conserved family of signal transducers. Trends Biochem Sci 22:267-272.
50. Wiegel PH, Fuller GM, and Le Boeuf RD (1986). A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 119:219-234.
51. West DC, Hampson IN, Arnold F, and Kumar S (1985). Angiogenesis induced by degradation products of hyaluronic acid. Science 228:1325-1326.
52. West DC and Kumar S (1987). Hyaluronan and angiogenesis. In: Evered D and Whelan J, editors: The biology of hyaluronan. Chichester, UK: Wiley and Sons, 187-201.
53. Xia P, Alello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, and King GL (1996). Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018-2026.
54. Xu S, Robbins D, Frost J, Dang A, Lange-Carter C, and Cobb MH (1995). MEKK1 phosphorylates MEK2 but does not cause activation of mitogen activated protein kinase. Proc Natl Acad Sci USA 92:6808-6812.